Neurological Disorders

FDA, Brain Disorder

FDA approves drug Trump touted for autism to treat other neurological disorder

The Food and Drug Administration approved leucovorin to treat a neurological disorder with some symptoms similar to autism.

· 15h

FDA Approves Drug for Rare Brain Disorder, Not Autism

· 1d · on MSN

FDA scales back vision for drug it touted as possible treatment for autism

· 1d

FDA Finds Little Evidence That a Drug Touted by Trump Can Help People With Autism

The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration officials that th...

· 1d

US FDA approves leucovorin for rare genetic disorder causing autism-like symptoms

· 1d

FDA contradicts Trump admin, declines to approve generic drug for autism

· 1d

FDA approves generic drug for a rare genetic condition, but not for autism

“While we did originally approach this with a broad scope, as we looked through the scientific data, we ended up narrowing our scope to come to the strongest data evidence that we could find to suppor...

STAT · 1d

Leucovorin lacks evidence to use as autism treatment, FDA says

· 1d

FDA approves generic drug for rare brain disorder but not autism

Facing A Global Challenge of Neurological Diseases

Neurological disorders affect over a third of the global population, presenting immense challenges for patients worldwide. Merz Therapeutics, a leading player in specialty neurology, aims to deliver better outcomes for more patients.

Healthline

What Are the Most Common Pediatric Neurological Disorders?

Neurological disorders affect the function of the nervous system. Common pediatric neurological disorders include ADHD, autism spectrum disorder, epilepsy, and cerebral palsy. Neurological disorders are conditions that affect the nervous system. Recent ...

17h

With $100M, Vima pursues an oral drug for movement disorders

Incubated by Atlas Venture, the biotech startup is advancing a daily pill it sees potentially helping people with dystonia or Parkinson's disease regain control of movement.

Hosted on MSN

WHO warns of lack of resources to treat neurological disorders

(NewsNation) — More than 1 in 3 people are living with a neurological condition, the World Health Organization found, and countries aren’t prepared to deal with it. The WHO’s Global status report on neurology found 40% of the global population is ...

Medical News Today

What are some common neurologic conditions in children?

A neurologic disorder is any condition that affects the brain and nerves throughout the body. Common neurologic conditions in children include epilepsy, cerebral palsy, attention deficit hyperactivity disorder (ADHD), and autism. Structural, chemical, or ...

28m

Differences Between Stimulant and Non-Stimulant Medications Shape Treatment Approaches for Attention Deficit Disorder

Stimulant medications and non-stimulant medications affect brain chemistry through different mechanisms”— Dr. Stanford

WVXU

Could GLP-1s help combat neurological disorders?

The study found that participants using GLP-1s were less likely to develop substance-use disorders or to have bad outcomes like overdosing. This comes at a time when manufacturers of these medications are studying whether GLP-1 drugs might aid symptoms of neurological disorders like schizophrenia.

Daijiworld

Mangaluru: Rise in neurological disorders among youth a concern: Dr Asha Kishore

In India, neurological diseases such as Multiple Sclerosis are increasingly being observed even among young people. The impact of these diseases is seen across all age groups. Considering various factors including genetic causes,

17h

Arvinas to Present Phase 1 Data for ARV-102, a PROTAC LRRK2 Degrader, in Oral Session at the 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and ...

Company to highlight new safety, pharmacokinetic, and pharmacodynamic data from Phase 1 clinical trial of ARV-102 in participants with Parkinson’s disease – NEW HAVEN, Conn., March 11, 2026 (GLOBE NEWSWIRE) -- Arvinas,

1 In 7 Indians Affected By Mental Health Disorders And Face Treatment Gaps: Experts

One in seven Indians is affected by mental health disorders, while several states continue to face a treatment gap ranging from 70 to 90 per cent as discussed in the post-budget webinar breakout session.